Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a leading medical cannabis company in the United States, has announced that its Board of Directors has authorized a share repurchase program. Under this program, the company may repurchase up to the lesser of $50 million in aggregate value or 8,495,038 subordinate voting shares, representing five percent of its issued and outstanding subordinate voting shares as of June 8, 2026. The repurchase program will be active for a 12-month period, concluding on June 16, 2027.
Strategic Capital Allocation
Kim Rivers, Founder and CEO of Trulieve, stated: "This program reflects our confidence in the long-term value of the business and our disciplined approach to capital allocation. We view share repurchases as an important tool to deliver value to shareholders when market conditions present a compelling opportunity, while maintaining the flexibility to invest in growth and strengthen our balance sheet."
Execution Details
Repurchases under the program will be conducted in accordance with applicable securities laws and regulations. The company is not obligated to acquire any specific number of shares and may suspend, modify, or discontinue the program at any time at its discretion. All subordinate voting shares purchased will be cancelled.
Forward-Looking Statements
This announcement includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. These statements involve risks and uncertainties that could cause actual results to differ materially. Key risk factors are detailed in Trulieve's Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent filings with the U.S. Securities and Exchange Commission and Canadian securities regulators.
About Trulieve
Trulieve is an industry-leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. The company is committed to expanding access to cannabis through innovative, high-quality products and exceptional customer experiences. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and on the OTCQX market under the symbol TCNNF.
For more information, visit Trulieve.com. Follow Trulieve on Facebook, Instagram, and X (formerly Twitter).
Investor and Media Contact: Christine Hersey, Chief Corporate Affairs and Strategy Officer, +1 (424) 202-0210, Christine.Hersey@Trulieve.com.
